Kang-Jye Chou

653 citations
11 papers · 246 indexed · h-index 8
Topics
Advanced Drug Delivery Systems (4 papers)Signaling Pathways in Disease (3 papers)Drug Transport and Resistance Mechanisms (3 papers)
Partner nations
United StatesFrance

In The Last Decade

Kang-Jye Chou

11 papers receiving 220 citations

Peers

Kang-Jye Chou
Comparison fields: 5 of 68
  • Pharmaceutical Science 138
  • Molecular Biology 86
  • Oncology 59
  • Materials Chemistry 29
  • Cellular and Molecular Neuroscience 20
Replace Dalapathi Gugulothu with:
Dalapathi Gugulothu India
Whei‐Mei Wu United States
Paul Moench United States
A. Gerlóczy Hungary
Teruki Hamada Japan
Marlyn Dian Laksitorini Indonesia
Jyoti Sharma United Kingdom
Jianxue Yang China
Riccardo Panicucci United States
Anne Christiansen United States
Kang-Jye Chou relative to Dalapathi Gugulothu India Dalapathi Gugulothu's profile →
Citations per field
00.5×4.5×
Dalapathi Gugulothu · 1×
Citations per year

Countries citing papers authored by Kang-Jye Chou

Since Specialization
Citations

This map shows the geographic impact of Kang-Jye Chou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kang-Jye Chou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kang-Jye Chou more than expected).

Fields of papers citing papers by Kang-Jye Chou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kang-Jye Chou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kang-Jye Chou. The network helps show where Kang-Jye Chou may publish in the future.

Co-authorship network of co-authors of Kang-Jye Chou

This figure shows the co-authorship network connecting the top 25 collaborators of Kang-Jye Chou. A scholar is included among the top collaborators of Kang-Jye Chou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kang-Jye Chou. Kang-Jye Chou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
#WorkIndexed citations
1 4
2 27
3 9
4 2
5 28
6 5
7 36
8 22
9 30
10 31
11 52

About Kang-Jye Chou

Kang-Jye Chou is a scholar working on Pharmaceutical Science, Oncology and Immunology and Allergy, having authored 11 papers that have together received 246 indexed citations. Recurring topics across this work include Advanced Drug Delivery Systems (4 papers), Signaling Pathways in Disease (3 papers) and Drug Transport and Resistance Mechanisms (3 papers). The work is most often cited by research in Pharmaceutical Science (138 citations), Sensory Systems (18 citations) and Oncology (59 citations). Kang-Jye Chou has collaborated with scholars based in United States and France. Frequent co-authors include Maureen D. Donovan, Po‐Chang Chiang, Yingqing Ran, Amy Sambrone, Harvey Wong, Yong Cui, Ryan Hart, Yuzhong Deng, Hank La and Yong Cui. Their work appears in journals such as Cancer Research, International Journal of Pharmaceutics and Nanoscale Research Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026